Status:

COMPLETED

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation

Lead Sponsor:

Indiana University School of Medicine

Collaborating Sponsors:

Abbott

Conditions:

Chronic Kidney Disease

Endothelial Dysfunction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study is about possible protective effects of paricalcitol (Zemplar) upon inflammation, blood pressure and kidney function. Kidney Inflammation occurs when white blood cells become abnormally stim...

Detailed Description

We hypothesize that use of paricalcitol in patients with chronic kidney disease will lead to improvement in oxidative stress, inflammation, endothelial function and subsequently ambulatory blood press...

Eligibility Criteria

Inclusion

  • Patients with chronic kidney disease with estimated GFR of 30 mL/minute or more.
  • Patients receiving stable dose of ACE inhibitor or Angiotensin receptor blockers for at least one month.
  • Patients not currently hypertensive more than 180/110 mmHg by clinic blood pressure.
  • Hemoglobulin A1C\< 11%

Exclusion

  • Patients taking vitamin D analogs
  • Calcium\> 10 mg/dL
  • Phosphorus\>6 mg/dL
  • Patients with anticipated need of dialysis in the next 6 weeks
  • Patients unstable in the opinion of the investigator
  • Patients who have emergent need for starting IV iron
  • Patients who will be started on statins within the next 6 weeks
  • Patients currently taking PDE5 inhibitors
  • Patients allergic to radiocontrast, Zemplar or who can not take nitroglycerin
  • Patients known to be HIV positive
  • Patients who can not give informed consent

Key Trial Info

Start Date :

November 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2007

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00428246

Start Date

November 1 2006

End Date

July 1 2007

Last Update

June 3 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Richard A. Rodebush VA Medical Center

Indianapolis, Indiana, United States, 46202

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation | DecenTrialz